Aerie Pharmaceuticals’ ROCK Inhibitor Demonstrates Positive Results in Glaucoma Patients in a Phase 2a Study

News   Oct 23, 2009

 
Aerie Pharmaceuticals’ ROCK Inhibitor Demonstrates Positive Results in Glaucoma Patients in a Phase 2a Study
 
 
 

RELATED ARTICLES

Gene Therapy Improves Heart Function by up to 25%

News

Intracoronary delivery of the gene vector was safe and improved heart function in a large animal model.

READ MORE

Cancer Cells’ Energy Source Blocked by Natural Compound

News

Researchers have not only untangled an unusual wiring system that cancer cells use for carbohydrate metabolism, but also identified a natural compound that appears to selectively shut down this system in laboratory studies.

READ MORE

How do Poison Frogs Protect Themselves Against Their Own Neurotoxin?

News

Scientists are a step closer to resolving a related head-scratcher, how do these frogs keep from poisoning themselves?

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE